NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wild Bioscience

Wild Bioscience

Private
AbingdonHealthcare & Life Scienceshttps://www.wildbioscience.com/

Last Round

Series A

Oct 16, 2025

Total Funding Raised

$93.32M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Wild Bioscience is an agritech company that develops high-yielding, climate-resilient crop varieties by using machine learning and plant biology to identify beneficial traits in wild plants.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

agricultural biotechnologyagtechprecision breedingcomputational genomicstrait discoverygene editingCRISPRclimate-resilient cropscrop designgenetically optimized seedscarbon sequestrationsynthetic biologyAI-driven biologybiotech R&Dbio-design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wild Bioscience Comps

Public and private peers based on sector, stage, and business model.

Wild Bioscience comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wild Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 16, 2025
GrantJul 1, 2022

Key People

Founding team and executive leadership

Ross Hendron

CEO & Co-Founder

Founding Team

Samuel Gattis

Chief Technology Officer

Executive Team

Wild Bioscience Investors

Notable investors and investment history

Wild Bioscience investors
InvestorRounds
Innovate UKGrant
Braavos Investment AdvisersSeed, Series A
Oxford Science EnterprisesSeed, Series A
University of OxfordSeries A
Innovate UKSeed
Oxford Science EnterprisesSeries A
Braavos CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Company is a spin-out from Oxford University.

  • Oct 16, 2025

    $60M Series A round completed.

Wild Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wild Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wild Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersAbingdon
Employee Range39
Year Founded2021
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.